{
  "docId": "019de071-b48b-74ad-8fcb-69ba4c0494fb",
  "docSlug": "4047dd7a7e0f28ca31128b58ef648c55",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 39,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Includes product-specific status updates for three key assets.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-b48b-74ad-8fcb-69ba4c0494fb/25",
  "deckHref": "/decks/019de071-b48b-74ad-8fcb-69ba4c0494fb",
  "deckJsonHref": "/decks/019de071-b48b-74ad-8fcb-69ba4c0494fb.json",
  "deckAnchorHref": "/decks/019de071-b48b-74ad-8fcb-69ba4c0494fb#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.13,
        "w": 0.09,
        "x": 0.87,
        "y": 0.71
      },
      "kind": "callout",
      "text": "US FDA Priority Review received for asthma",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2554776f-0a9a-4ede-9f01-10127a4ef752",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.31,
        "x": 0.35,
        "y": 0.78
      },
      "kind": "callout",
      "text": "Regulatory submission anticipated in H1 2022",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4dfbd9e3-6ae6-43da-8be5-d6141be50690",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.13,
        "x": 0.21,
        "y": 0.585
      },
      "kind": "image",
      "text": "Saphnelo product packaging",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc181a31-f995-4b31-9a46-7cfcff080786",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.31,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "list",
      "text": "Saphnelo: Systemic lupus erythematosus; Received US and Japan approval; AHEG scheduled ahead of EU regulatory decision; Phase III trial for subcutaneous delivery underway",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08dd6cc0-9851-47c2-ad4c-7a8d8256f12f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.31,
        "x": 0.66,
        "y": 0.23
      },
      "kind": "list",
      "text": "Tezepelumab: Asthma; Regulatory submission completed in US, EU and Japan; Regulatory decisions expected H1 2022; Orphan Drug Designation in US - eosinophilic oesophagitis; Phase III trial in nasal polyps underway",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d65b850-47e8-4c50-a55e-328962ab7643",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.31,
        "x": 0.35,
        "y": 0.23
      },
      "kind": "list",
      "text": "PT027: Asthma; Positive phase III results from both MANDALA and DENALI trials; Potentially the first albuterol/ICS combination rescue therapy for the US; Positioned to replace traditional rescue SABA approach",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d821174b-4065-43d7-b7ed-6c4dc26e50e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.92,
        "x": 0.04,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "AHEG = ad-hoc expert group; ICS = inhaled corticosteroid; SABA = short acting beta agonist. PT027 is being developed in collaboration with Avillion Inc. Tezepelumab is being developed in collaboration with Amgen Inc.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f88421a9-db0d-41a4-ae67-e736cccb05bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.42,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Potential to change standards of care",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38394945-2ec6-4b0c-881f-8bc9bc351619",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Respiratory & Immunology: R&D pipeline highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15b8b3b1-b854-489e-83a5-962cb18be422",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "c7aa47c3-bb6e-476c-8503-0467c50f89fe",
      "evidence": "The slide presents information in a list format, with bullet points highlighting R&D pipeline highlights for Respiratory & Immunology.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 27,
      "from": 21,
      "beatId": "20be7aa9-aa56-49cc-a307-59bd4a0f6852",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Visualization",
      "beatSlug": "monroes-sequence-visualization",
      "evidence": "The document provides a clear roadmap for the company's future growth and innovation.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}